23-Valent Pneumococcal Polysaccharide Vaccine Market Report

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：138
  • REPORT CODE：GMM826715
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • 23-Valent Pneumococcal Polysaccharide Vaccine market report explains the definition, types, applications, major countries, and major players of the 23-Valent Pneumococcal Polysaccharide Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • CDIBP

    • MSD

    • Sanofipasteur

    By Type:

    • Single Dose Vial

    • Pre-filled Syringe

    By End-User:

    • For Children (2-10)

    • For Person (10-64)

    • For The old (Above 65)

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 23-Valent Pneumococcal Polysaccharide Vaccine Outlook to 2028- Original Forecasts

    • 2.2 23-Valent Pneumococcal Polysaccharide Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market- Recent Developments

    • 6.1 23-Valent Pneumococcal Polysaccharide Vaccine Market News and Developments

    • 6.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Deals Landscape

    7 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials

    • 7.2 23-Valent Pneumococcal Polysaccharide Vaccine Price Trend of Key Raw Materials

    • 7.3 23-Valent Pneumococcal Polysaccharide Vaccine Key Suppliers of Raw Materials

    • 7.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate of Raw Materials

    • 7.5 23-Valent Pneumococcal Polysaccharide Vaccine Cost Structure Analysis

      • 7.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials Analysis

      • 7.5.2 23-Valent Pneumococcal Polysaccharide Vaccine Labor Cost Analysis

      • 7.5.3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Expenses Analysis

    8 Global 23-Valent Pneumococcal Polysaccharide Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Single Dose Vial Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pre-filled Syringe Consumption and Growth Rate (2017-2022)

    • 9.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global For Children (2-10) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global For Person (10-64) Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global For The old (Above 65) Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.2.2 Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.2 UK 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.3 Spain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.5 France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.6 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.8 Finland 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.9 Norway 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.11 Poland 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.12 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.3 India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.3 Chile 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.6 Peru 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.6.3 Oman 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    11 Global 23-Valent Pneumococcal Polysaccharide Vaccine Competitive Analysis

    • 11.1 CDIBP

      • 11.1.1 CDIBP Company Details

      • 11.1.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

      • 11.1.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 MSD

      • 11.2.1 MSD Company Details

      • 11.2.2 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

      • 11.2.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Sanofipasteur

      • 11.3.1 Sanofipasteur Company Details

      • 11.3.2 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

      • 11.3.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    12 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Single Dose Vial Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Pre-filled Syringe Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global For Children (2-10) Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global For Person (10-64) Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global For The old (Above 65) Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of 23-Valent Pneumococcal Polysaccharide Vaccine

    • Figure of 23-Valent Pneumococcal Polysaccharide Vaccine Picture

    • Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Single Dose Vial Consumption and Growth Rate (2017-2022)

    • Figure Global Pre-filled Syringe Consumption and Growth Rate (2017-2022)

    • Figure Global For Children (2-10) Consumption and Growth Rate (2017-2022)

    • Figure Global For Person (10-64) Consumption and Growth Rate (2017-2022)

    • Figure Global For The old (Above 65) Consumption and Growth Rate (2017-2022)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table CDIBP Company Details

    • Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

    • Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio

    • Table MSD Company Details

    • Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

    • Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio

    • Table Sanofipasteur Company Details

    • Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

    • Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio

    • Figure Global Single Dose Vial Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pre-filled Syringe Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global For Children (2-10) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global For Person (10-64) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global For The old (Above 65) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US